Back to companies

Esperion Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Esperion Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Esperion Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

J. Martin Carroll

Chairman Executive Board Since: 2022 Age: 76

Sheldon L. Koenig

Director; President; Chief Executive Officer Executive Board Since: 2021 Age: 60

Benjamin Halladay

Chief Financial Officer Senior Management Since: 2022 Age: 40

Betty Jean Swartz

Chief Business Officer Senior Management Since: 2023

John B. Harlow

Chief Commercial Officer Senior Management Since: 2025 Age: 50
Gain a 360-degree view of Esperion Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Esperion Therapeutics Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer